#Asia-Pacific Antivenom Market

[jayanthitbrc]

Global Antivenom Market Overview – Market Growth Analysis And Key Drivers

The Antivenom Global Market Report 2023, provides comprehensive information on the antivenom market across 60+ geographies in the seven regions - Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The report covers a ten year historic period – 2010-2021, and a ten year forecast period – 2023-2032.

Learn More On The Antivenom Market’s Growth:

The global antivenom market size is expected to grow from $1.66 billion in 2022 to $1.80 billion in 2023 at a compound annual growth rate (CAGR) of 8.2%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The antivenom market size is expected to reach $2.37 billion in 2027 at a CAGR of 7.1%.

Get A Free Sample Of The Report (Includes Graphs And Tables):

Product innovations are a key trend gaining popularity in the antivenom market. Companies operating in the antivenom market are developing innovative products to sustain their position in the market. For instance, in April 2021, Rare Disease Therapeutics, Inc., a US-based pharmaceutical company, launched Antivenom ANAVIP®, a new expanded FDA-approved indication. This medication is licensed to treat pit viper bites in adults and children, including rattlesnakes, copperheads, and cottonmouth/water moccasins. It was created with a lengthy half-life to lessen the possibility of re-emergent venom effects (such as platelet drop, longer bleeding times, and other abnormal blood coagulation tests), which commonly necessitated additional doses of a shorter-acting antivenom.

The antivenom market is segmented:

1) By Type: Monovalent, Polyvalent, Other Types

2) By Animal: Snakes, Scorpions, Spiders, Other Animals

3) By Mode of Action: Cytotoxic, Neurotoxic, Haemotoxic, Cardiotoxic, Myotoxic, Other Modes Of Action

4) By End User: Hospitals, Clinics, Ambulatory Surgical Centers, Other End-Users

North America was the largest region in the antivenom market in 2022.

The table of contents in TBRC’s antivenom market report includes:

1. Executive Summary

2. Market Characteristics

3. Market Trends And Strategies

4. Impact Of COVID-19

5. Market Size And Growth

6. Segmentation

7. Regional And Country Analysis

.

.

.

27. Competitive Landscape And Company Profiles

28. Key Mergers And Acquisitions

29. Future Outlook and Potential Analysis

Learn About Us:  The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries. Through the report businesses can gain a thorough understanding of the market’s size, growth rate, major drivers and leading players.

Contact Us:  The Business Research Company  Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

[nitasonwane]

Snake Antivenom Market 2023-2030

The global snake antivenom market size was valued at USD 294.8 million in 2021. The market is projected to grow from USD 312.9 million in 2022 to USD 526.0 million by 2029, exhibiting a CAGR of 7.7% during the forecast period.

This information is presented by Fortune Business Insights, in its report titled, “Snake Antivenom Market, 2022-2029.”

COVID-19 Impacts:

Supply Chain Disruptions and Halt in Hospital Admissions Hindered Market Growth

Increased wait time before seeking treatment and delays in hospital admission due to imposition of stringent lockdowns and social distancing norms to curb the spread of the pandemic hampered market augmentation. Moreover, supply chain disruptions and diversion of healthcare budgets, beds, equipment and professionals towards dealing with the ongoing pandemic also impacted market trends negatively.

To get to know more about the short-term and long-term impact of COVID-19 on this market, please visit:

Segments:

Polyvalent Heterologous Segment to Lead Owing to its Convenience

Based on type, the market is divided into polyvalent heterologous and monovalent heterologous. Among these, the polyvalent heterologous segment captured the largest market share due to its preference over monovalent antivenom. Polyvalent antivenom has the ability to neutralize the venomous bite of several snake species and is thus preferred as it helps in cases when the species can’t be identified.

Hospitals Segment to Grow Backed by Increasing Hospital Admissions

As per application, the market is bifurcated into hospitals and clinics. Hospitals segment captured majority of the market due to rising number of hospital admissions. Hospitals provide facilities such as focused treatment, personalized care, and others which will also propel this segment.

Geographically, the market is segregated into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

[jayparkar-us-blog]

Asia-Pacific Antivenom Market : Strategic Directions to Gain High Share In 2021

“Asia-Pacific Antivenom Market By Type [Vaccines And Hyperimmune Sera (Homologous & Heterologous)] And By Animal (Snakes, Scorpions, Spiders, And Others) - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2016-2021)” is a professional and incisive analysis on the market dynamics of the Asia-Pacific Antivenom Market industry and future growth prospects of the key market players across the global. The study offers detailed quantitative and qualitative analysis of the industry by offering an overview of key market conditions and statistics on market estimations. An in-depth insight into the industry overview is offered in the study in terms of product definition and classification, applications analysis and manufacturing technology. The market participants can going through the study explore the profile of international market players in terms of their capacity utilization, market shares of the major segments, growth opportunities and challenges they need to overcome to gain a foothold in the market.

Click here for sample report @ https://www.researchtrades.com/request-sample/1090902

Asia-Pacific Antivenom Market is expected to reach USD 325.7 million by 2021 from USD 215.7 million in 2016, growing at a CAGR of 8.59% during the forecast period 2016-2021. Antivenom is described as the biological product that detoxifies poisoning of venomous bites. Antivenom is prepared from the milking venom of animals such as snakes, spiders, scorpions, and other venomous animals. Venomous bites result in certain clinical conditions such as secretion of excessive saliva, muscle weakness, breathing problems, and other difficulties that may lead to death also. It is estimated that, approximately 40,000-80,000 people die in Asia (Majorly from India) with snake bites annually. To overcome poisonous effects after venomous bites the manufacturers developed number of Antivenom products including vaccines and hyperimmune sera.

Rising demand for antivenom products, growing number of snake bite cases as compared to developed regions, development of effective antivenom products against more number of snake species, and increasing number of manufacturers to focus on antivenom products in the Asia region (especially in India) are driving the growth of Asia-Pacific Antivenom Market. However, dearth of antivenom products, high cost of the products, existence of new regulations, requirement of training to medical staffs, and presence of underdeveloped medical infrastructure are restraining the growth of the Asia-Pacific Antivenom Market.

Asia-Pacific Market for Antivenom is broadly categorized into type and animal. On the basis of type, Asia-Pacific Antivenom market is segmented into Vaccines and Hyperimmune Sera (Homologous & Heterologous). Based on animal the market is segmented into Snakes, Scorpions, Spiders, and Others.

Geographically, Asia-Pacific Antivenom market is segmented into China, India, Japan, South Korea, and Australia. Asia-Pacific is the fastest growing region with a CAGR of 8.59% during the forecast period 2016-2021.

Key market players in the Antivenom market include Instituto Bioclon, S.A. de C.V. (Mexico), Pfizer AG (Switzerland), CSL Limited (Australia), F. Hoffmann-La Roche Ltd. (Switzerland), Merck & Co., Inc. (U.S.), Rare Disease Therapeutics, Inc. (U.S.), Vins Bioproducts Limited (India), BTG Plc (U.K.), Incepta Vaccine Ltd. (Bangladesh), and Bharat Serum and Vaccines Limited (BSV) (India).

Buy a Copy of this report for a single user price of $ 3335 @ https://www.researchtrades.com/checkout/1090902

Key Chapter

1. Introduction

1.1 Market Definition

1.2 Study Deliverables

1.3 Base Currency, Base Year and Forecast Periods

1.4 General Study Assumptions

2. Research Methodology

2.1 Introduction

2.2 Research Phases

2.2.1 Secondary Research

2.2.2 Primary Research

2.2.3 Econometric Modelling

2.2.4 Expert Validation

2.3 Analysis Design

2.4 Study Timeline

3. Overview

3.1 Executive Summary

3.2 Key Inferences

3.3 Epidemology

Continue………….

Browse for report customization @ https://www.researchtrades.com/report-customization

Who we are

Research Trades has team of experts who works on providing exhaustive analysis pertaining to market research on a global basis. This comprehensive analysis is obtained by a thorough research and study of the ongoing trends and provides predictive data regarding the future estimations, which can be utilized by various organizations for growth purposes.

We distribute customized reports that focus on meeting the client’s specific requirement. Our database consists of a large collection of high-quality reports obtained using a customer-centric approach, thus providing valuable research insights. The research encompasses information gathered and examined by subject-matter experts, laying down growth opportunities and developmental strategies for enterprises.

Reach at us:

Email: sales@researchtrades.com          

Call us: +1 6269994607 / +91 7507349866

Skype ID: researchtradescon

Web: http://www.researchtrades.com

[xyz35569]

“Anti-Venom  Market ”gives detailed outlook by Type, by Application, by Segmentation and Regional Forecasts.

[crediblemarkets20]

Antivenom Market 2022 Industrial Chain, Regional Scope, Key Players Profiles and Sales Data to 2028

The Antivenom Market was esteemed at USD 969.38 million of every 2020 and it is expected to arrive at USD 1585.01 million out of 2026, by enlisting the CAGR of almost 8.54% during the gauge time frame.

There is a critical expansion in the quantity of passings detailed because of snake nibbles during the COVID-19 pandemic in couple of regions. This is driving a generous interest for neutralizing agents toxins. In excess of 350 snake chomps were accounted for in Texas in 2020, which is an expansion of 40% over the worth enrolled in 2019, according to the June 2020 article named “Texas snake nibbles expanding during COVID-19 pandemic”.

Snakebite is one of the dismissed general medical problems in numerous tropical and subtropical nations. As indicated by World Health Organization (WHO) in 2017, around 5.4 million snake nibbles happen every year, coming about in up to 2.7 million envenoming’s (harming from snake chomps) and around 81,000 to 131,000 passing because of snake chomps. Also, it frequently prompts around three fold the number of removals and other super durable inabilities on the planet.

Likewise, as per a review distributed by the diary eLife in 2019, India has seen an expected 1.2 million passings because of snakebites between 2001-2020. The review included general wellbeing scientists and herpetologists from India, the UK, and Canada.

Request for a sample report here@ https://www.crediblemarkets.com/sample-request/antivenom-market-372754

Some of the key industry players that are operating in the Antivenom are:

CSL Merck BTG Pfizer Haffkine Bio-Pharmaceutical Rare Disease Therapeutics Flynn Pharma Vins Bioproducts Bharat Serums and Vaccines Serum Biotech MicroPharm

KEY MARKET INSIGHTS:

In light of the creature type, the snake nibbles fragment is expected to represent the majority of the offer in the worldwide antibody market during the conjecture time frame.

Topographically, Asia-pacific is anticipated to lead the market during the gauge time frame. In APAC nations like India and Bangladesh, snake nibbles are fundamentally developing, which is assessed to help the area register a high development rate among all districts.

In 2020, the African market had a sound development rate. The market is the driver with the expansion in Scorpio nibbles and snake chomps, particularly in the sub-Saharan locale, and government drives to give assets to satisfy the serious need for antibody toxin items. In 2019, around 20,500 lives were lost from snakebites in Africa, and the numbers are assessed to reach 200,000 throughout the following decade. Furthermore, many individuals will experience long-lasting deformation because of removal and inability because of effect to the neuromuscular framework in the body. Notwithstanding, concentrates on recommended that main 9% of snakebite casualties in Nigeria and 28 percent in Kenya looked for emergency clinic treatment in 2019.

Worldwide Snakebite Initiative and African legislatures, foundations, and organizations are cooperating to work on the existences of Africans. This large number of variables will give better development freedoms to the market while decidedly driving the market for quite a long time in the future.

Instituto Bioclon, S.A. de C.V. (Mexico), Pfizer AG (Switzerland), CSL Limited (Australia), F. Hoffmann-La Roche Ltd. (Switzerland), Merck and Co., Inc. (U.S.), Rare Disease Therapeutics, Inc. (U.S.), Vins Bioproducts Limited (India), BTG Plc (U.K.), Incepta Vaccine Ltd. (Bangladesh) and Bharat Serum are a portion of the vital organizations working in the worldwide counter-agent market.

The Antivenom is segmented into Product Types:

Polyvalent antivenom Monovalent antivenom

The Antivenom is segmented into By End User/Application:

Non-profit Institutions Hospitals and Clinic

Regional Segmentation

North America United States Canada Asia-Pacific China Japan South Korea India Southeast Asia Australia Rest of Asia-Pacific Europe Germany France U.K. Italy Russia Nordic Countries Rest of Europe Latin America Mexico Brazil Rest of Latin America Middle East & Africa Turkey Saudi Arabia UAE Rest of MEA

Buy Now@ https://www.crediblemarkets.com/reports/purchase/antivenom-market-372754?utf8=%E2%9C%93&license_type=single_user

Motivations to Purchase this Report:

Qualitative and quantitative examination of the market dependent on division including both monetary just as non-financial variables

Provision of market esteem (USD Billion) information for each portion and sub-fragment

Indicates the district and fragment that is relied upon to observe the quickest development just as to overwhelm the market

Analysis by geology featuring the utilization of the item/administration in the area just as showing the variables that are influencing the market inside every district

Competitive scene which consolidates the market positioning of the central parts, alongside new help/item dispatches, associations, business extensions and acquisitions in the beyond five years of organizations profiled

Extensive organization profiles containing organization outline, organization experiences, item benchmarking and SWOT examination for the significant market players

The ebb and flow just as the future market viewpoint of the business regarding late turns of events (which include development openings and drivers just as difficulties and limitations of both arising just as evolved areas

Includes an inside and out investigation of the market of different viewpoints through Porter’s five powers examination

Provides knowledge into the market through Value Chain

Market elements situation, alongside development chances of the market in the years to come

half year post-deals investigator support

Some Major Points of Table of Content:

1 Study Coverage 1.1 Antivenom Product Introduction 1.2 Market by Type 1.2.1 Global Antivenom Market Size Growth Rate by Type 1.2.2 Polyvalent antivenom 1.2.3 Monovalent antivenom 1.3 Market by Application 1.3.1 Global Antivenom Market Size Growth Rate by Application 1.3.2 Non-profit Institutions 1.3.3 Hospitals and Clinic 1.4 Study Objectives 1.5 Years Considered

2 Executive Summary 2.1 Global Antivenom Market Size Estimates and Forecasts 2.1.1 Global Antivenom Revenue 2016-2027 2.1.2 Global Antivenom Sales 2016-2027 2.2 Antivenom Market Size by Region: 2021 Versus 2027 2.3 Antivenom Sales by Region (2016-2027) 2.3.1 Global Antivenom Sales by Region: 2016-2021 2.3.2 Global Antivenom Sales Forecast by Region (2022-2027) 2.3.3 Global Antivenom Sales Market Share by Region (2016-2027) 2.4 Antivenom Market Estimates and Projections by Region (2022-2027) 2.4.1 Global Antivenom Revenue by Region: 2016-2021 2.4.2 Global Antivenom Revenue Forecast by Region (2022-2027) 2.4.3 Global Antivenom Revenue Market Share by Region (2016-2027)

3 Global Antivenom by Manufacturers 3.1 Global Top Antivenom Manufacturers by Sales 3.1.1 Global Antivenom Sales by Manufacturer (2016-2021) 3.1.2 Global Antivenom Sales Market Share by Manufacturer (2016-2021) 3.2 Global Top Antivenom Manufacturers by Revenue 3.2.1 Global Antivenom Revenue by Manufacturer (2016-2021) 3.2.2 Global Antivenom Revenue Share by Manufacturer (2016-2021) 3.3 Global Antivenom Price by Manufacturer (2016-2021) 3.4 Competitive Landscape 3.4.1 Key Antivenom Manufacturers Covered: Ranking by Revenue 3.4.2 Global Antivenom Market Concentration Ratio (CR5 and HHI) & (2016-2021) 3.4.3 Global Antivenom Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.5 Global Antivenom Manufacturing Base Distribution, Product Type 3.5.1 Antivenom Manufacturers Manufacturing Base Distribution, Headquarters 3.5.2 Manufacturers Antivenom Product Type 3.5.3 Date of International Manufacturers Enter into Antivenom Market 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

Click here for complete TOC:

About Us

Credible Markets has emerged as a dependable source for the market research needs of businesses within a quick time span. We have collaborated with leading publishers of market intelligence and the coverage of our reports reserve spans all the key industry verticals and thousands of micro markets. The massive repository allows our clients to pick from recently published reports from a range of publishers that also provide extensive regional and country-wise analysis. Moreover, pre-booked research reports are among our top offerings.

Contact Us

Credible Markets Analytics

99 Wall Street 2124 New York, NY 10005

Email: sales@crediblemarkets.com

[myabhijitr]

Anti-Venom Market to Booming $729.9 Mn, Globally by 2026 at a 4.7% CAGR : Coherent Market Insights

Anti-venom, sometimes called anti-venomine, anti-venom, and venom antidote, is a medical remedy for envenoming. It consists of antibodies specifically produced to counter-venoms caused by insects. Antivenoms are generally recommended only in cases of severe poisoning or if there is a high probability of serious toxicity. People allergic to poison ivy, trypanosporiasis, bee stings, and other potentially hazardous plants are not recommended to take anti-venoms. An allergy to bee stings can cause anaphylactic shock, which results in symptoms such as nausea, difficulty breathing, and swelling of the face and throat. People can have an acute allergic reaction when they are exposed to snakes that secrete venom in their saliva.

Get Sample Report with Latest Covid19 Impact Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/1249

Competitive Landscape

Major companies contributing to the global anti-venom market include Bharat Serums and Vaccines Limited, Merck & Co., Inc., CSL Limited, Laboratorios Silanes, BTG plc., Rare Disease Therapeutics, Incepta Pharmaceuticals Ltd., Pfizer, Inc., Vins Bioproducts Limited, and Haffkine Bio-Pharmaceutical Corporation Ltd.

Drivers

Elevated fatality rates as a result of snakebites coupled with growing occurrences of envenomation-driven symptoms are expected to augment growth of the anti-venom market during the forecast period.

In addition to this, increasing expenditure on the development of anti-venoms as a potential cure for paralysis and other medical conditions is expected to aid growth of the anti-venom market throughout the forecast period.

The Epitome of the COVID-19 Aftermath

The global anti-venom market has shown a decent sign of upswing during the prevalence of the COVID-19 virus. The rural areas have witnessed a steep rise in the envenoming cases. Coupled with this, rural places have also seen homecoming of working population from the urban space amidst adoption of the remote-work model.

Buy This Complete Business Report @: https://www.coherentmarketinsights.com/insight/buy-now/1249

Key Takeaways

• The anti-venom market is anticipated to grow at a CAGR of XX % throughout the forecast period on the heels of rising incidences of snakebites and growing government support. For instance, in May 2021, the World Health Organization (WHO) reported that around 2.7 million individuals suffer from envenoming and its resultant symptoms.

• On the geographical front, the Asia Pacific region is a treasure island for the global anti-venom market at the helm of a large envenom caseload (nearly 2 million annually as per WHO) and growing demand from wildlife sanctuaries.

• Bubbling under the top spot, the African region is another hot favorite for the global anti-venom market in the view of a vast rural area and the presence of several venomous snake species.

[medicaldevicetech]

Anti-Venom Market 2020- Analysis and Trends

Anti-Venom Market Driven by Enhancing Regulatory Framework

The recent report by Market Research Future (MRFR) predicts the global anti-venom market value will be expanding with a healthy CAGR of 6.5% over the forecast period (2017–2023).

Biotechnology, as well as the healthcare industry, is noting a considerable demand from developing nations globally. The prominent reason behind the strong growth of the anti-venom market is the growing demand for anti-venom treatment, as it is the only authorized treatment for snake bite, without any alternative treatment available. Moreover, violation of forest lands for housing and agricultural needs has gotten humans close to poisonous animals and insects, thereby increasing the prevalence of venomous bites. In addition, the prevalence of snake bites, scorpion bites, as well as other animal or insect bites like fish stings is an additional factor playing a major role in the anti-venom market growth.

Various research and development (R&D) activities taking place continuously that provide advanced drugs and standard treatment for poisonous insect bite further uplifts the market position of anti-venom. Growing demand for anti-venoms in the emerging countries is encouraging the prominent players to penetrate these markets, such as in India and Africa in order to offer anti-venom products at a cost-effective price. This is yet another driver responsible for the growth of the global anti-venoms market.

In contrast, the high cost of anti-venom due to the high production cost in a few regions could hamper the growth of the anti-venom market. However, the rapid development of the economic conditions around the world is creating massive opportunities for the expansion of the anti-venom market. The improving economy is increasing the individual per capita income, which will increase the spending capacity on health care. The contribution of the developing countries of Asia Pacific as well as the Middle East coupled with the growing population and increasing capita income will foster the growth of the market.

Segmentation

The global anti-venom market is segmented on the basis of type, type of species, mode of action, product type, and end user.

The global anti-venom market, by type, is categorized into polyvalent heterologous antivenom, monovalent heterologous antivenom, homologous antivenom, and small molecule anti-toxins.

By species type, the global anti-venom market is segmented into snakes, scorpions, spiders, and others. The snake segment is further classified as a common cobra, common krait, Russell Viper, and others.

Based on the mode of action, the global anti-venom market is divided into cytotoxic, neurotoxic, haemotoxic, cardiotoxic, myotoxic, and others.

The product types in the global anti-venom market include snake anti-venom, scorpion anti-venom, spider anti-venom, and others.

End-user-wise, the global anti-venom market is segmented into hospitals, clinics, ambulatory surgical centers, and others.

Regional Analysis

The regions among which the global anti-venom market is segmented into are Asia Pacific, Europe, Americas, and the Middle East and Africa.

At a global level, the Americas will be leading the anti-venom market in the coming years on account of the increasing cases of snake bites, as well as scorpion bites coupled with the high healthcare expenditure.

Europe will be securing the second position in the global anti-venom market, due to the strong financial support by the government for research and development along with the improvement in reimbursement scenario, driving the Europe anti-venom market. As per the data furnished by Eurostat, it is noted that among all the EU Member States, the highest value of healthcare expenditure has been recorded in Germany in the year 2014, which was around EUR 321 billion, followed by France at the value of EUR 237 billion and United Kingdom valued at EUR 223 billion. In the year 2016, the R&D expenditure for the pharmaceutical industry was at the value of EUR 35000 million, stated by the European Federation of Pharmaceutical Industries and Association.

Furthermore, Asia Pacific is touted to be the fastest growing anti-venom market, resulting from the massive patient pool coupled with the increasing advancements in pharmaceuticals. As per the Indian Brand Equity Foundation (IBEF), the generics market in the country was around USD 26.1 billion in the year 2016. Moreover, according to the statistics by the World Health Organization (WHO), around 2.8 million people are bitten by snakes, and close to 46 900 people succumb to snakebites every year.

Lastly, the market in the Middle East and Africa account for the lowest share of the global market owing to the restricted economic development, lack of technical knowhow, and poor medical facilities.

Competitive Landscape

Thermo Fisher Scientific, Ypsomed Holding AG, Artsana S.p.a., B. Braun Melsungen AG, Becton, Dickinson and Company, Allison Medical, Inc., cHill-Rom, Hu-Friedy Mfg. Co., LLC, Johnson & Johnson Services, Inc, Medline Industries, Inc., Medtronic plc, Allison Medical, Inc., Owen Mumford, Ltd., Roboz Surgical Instrument, Smiths Medical, Stryker Corporation, Terumo Corporation, Novo Nordisk A/s, UltiMed, Inc., Boston Scientific Corporation, are some of the leading companies in the global anti-venom market.

Industry Update

February 2019 – Kenya’s Ministry of Health is set to produce anti-snake venom for ensuring a sustainable supply, in addition to developing few policies, guidelines as well as processes for identifying cheaper high-quality brands for licensing. The products will be procured and distributed to public health facilities by the country’s medical supplies authority.

Read More @https://www.marketresearchfuture.com/reports/anti-venom-market-5859

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact: Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune – 411028 Maharashtra, India +1 646 845 9312 Email: sales@marketresearchfuture.com

NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

[dd-markets-trends]

Global Antivenom Market 2019 | Manufacturers In-Depth Analysis Report to 2024

The latest trending report Global Antivenom Market 2019-2024 added by DecisionDatabases.com.

The worldwide market for Antivenom is expected to grow at a CAGR of roughly 2.5% over the next five years, will reach 964.2 million US$ in 2024, from 873.9 million US$ in 2019.

This report focuses on the Antivenom in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Browse the complete report and table of contents @ https://www.decisiondatabases.com/ip/24328-antivenom-market-analysis-report

Market Segment by Manufacturers, this report covers

    CSL Behring

    Vins Bioproducts

    Pfizer

    Merck & Co.

    Flynn Pharma

    BTG Plc

    Serum Biotech

    Rare Disease Therapeutics

    Haffkine Bio-Pharmaceutical Corporation

    Bharat Serums and Vaccines

Market Segment by Regions, regional analysis covers

    North America (United States, Canada and Mexico)

    Europe (Germany, France, UK, Russia and Italy)

    Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

    South America (Brazil, Argentina, Colombia etc.)

    Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

    Polyvalent antivenom

    Monovalent antivenom

Market Segment by Applications, can be divided into

    Retail Pharmacies

    Hospitals

    Others

Download Free Sample Report of Global Antivenom Market @ https://www.decisiondatabases.com/contact/download-sample-24328

The content of the study subjects, includes a total of 15 chapters: Chapter 1, to describe Antivenom product scope, market overview, market opportunities, market driving force and market risks. Chapter 2, to profile the top manufacturers of Antivenom, with price, sales, revenue and global market share of Antivenom in 2017 and 2018. Chapter 3, the Antivenom competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast. Chapter 4, the Antivenom breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019. Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019. Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019. Chapter 12, Antivenom market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024. Chapter 13, 14 and 15, to describe Antivenom sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Purchase the complete Global Antivenom Market Research Report @ https://www.decisiondatabases.com/contact/buy-now-24328

Other Reports by DecisionDatabases.com:

Global Feed Probiotics Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Global Antifreeze Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Global Prebiotics Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

About-Us: DecisionDatabases.com is a global business research reports provider, enriching decision makers and strategists with qualitative statistics. DecisionDatabases.com is proficient in providing syndicated research report, customized research reports, company profiles and industry databases across multiple domains.

Our expert research analysts have been trained to map client’s research requirements to the correct research resource leading to a distinctive edge over its competitors. We provide intellectual, precise and meaningful data at a lightning speed.

For more details: DecisionDatabases.com E-Mail: sales@decisiondatabases.com Phone: +91 9028057900 Web: https://www.decisiondatabases.com/

[saojip13]

Antivenom Market Grow Around 6.0% CAGR Over 2019-2025

Global Antivenom Market: Global antivenom market was valued around US$ 1,100 Mn in 2016 and poised to grow around 6.0% CAGR over 2019-2025.

Global Antivenom Market Report Description: Global antivenom market report gives comprehensive outlook on antivenom products across the globe with special emphasis on key regions such as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa (MEA). The report on antivenom market gives historical, current, and future market sizes (US$ Mn) on the basis of antivenom type, reptile type, immunoglobulin type, distribution channel, and geographic regions.

This report studies antivenom market dynamics elaborately to identify the current market trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, antivenom market report includes the competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, antivenom market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs.

Get a Sample Copy of this Report @ https://www.alexareports.com/report-sample/170550

Key stakeholders of the antivenom market report include raw material suppliers, manufacturers, marketers, hospitals, physician offices, policy makers, and healthcare service providers who are engaged in usage and advocacy of antivenom products.

Competition Assessment Key players profiles in the global antivenom market include: • Vins Bioproducts Limited (India) • Bharat Serum and Vaccines Limited (India) • CSL Limited (Victoria) • Rare Disease Therapeutics, Inc. (U.S.) • F. Hoffmann-La Roche AG (Switzerland) • Instituto Bioclon, S.A. de C.V.(Mexico) • Incepta Vaccine Ltd. (Bangladesh) • BTG Plc (UK) • Merck & Co., Inc. (U.S) • Pfizer Inc. (U.S.)

Grab amazing discount here @ https://www.alexareports.com/check-discount/170550

Key Features of the Report:

• The report provides granular level information about the market size, regional market share, historic market (2014-2018) and forecast (2019-2025) • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market • The report tracks recent innovations, key developments and startup’s details that are actively working in the market • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Detailed Segmentation

By Antivenom Type o Monovalent o Bivalent o Trivalent o Tetravalent o Polyvalent

By Reptile Type o Snakes o Scorpions o Spiders o Others

By Immunoglobulin Type o Homologous o Heterologous

By Distribution Channel o Hospital Pharmacies o Retail Pharmacies o Others

To Enquire About This Comprehensive Report@ https://www.alexareports.com/send-an-enquiry/170550

Key benefits of buying this profile include: You get detailed information about the company and its operations to identify potential customers and suppliers. – The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors. Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company. – The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events. Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably. – Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted. Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance. – Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios. Gain key insights into the company for academic or business research. – Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Follow Us:

https://www.linkedin.com/company/alexa-report

https://www.facebook.com/alexareportsinc

https://twitter.com/Alexa_Reports

[nitasonwane]

Snake Antivenom Market 2023-2029

Snake antivenom is a specific type of antivenom used to treat individuals who have been bitten by venomous snakes. When a venomous snake bites a person, it injects venom into the bloodstream through its fangs. This venom can be highly toxic and may cause various symptoms, ranging from local pain, swelling, and tissue damage to more severe systemic effects like paralysis, respiratory distress, and even death.

The global snake antivenom market size was valued at USD 294.8 million in 2021. The market is predicted to grow from USD 312.9 million in 2022 to USD 526.0 million by 2029, exhibiting a CAGR of 7.7% during the forecast period.

Global Snake Antivenom Market: Drivers and Restraints:

Snake antivenom is the primary treatment for snakebite envenomation. It is made by immunizing animals, such as horses or sheep, with small, non-lethal amounts of snake venom. The animals' immune systems respond by producing antibodies against the venom. These antibodies are then collected and purified to create the antivenom.

When administered to a snakebite victim, the antivenom works by neutralizing the toxic effects of the snake's venom, helping to prevent or reverse the symptoms of envenomation. The earlier the antivenom is administered after the snakebite, the more effective it tends to be in mitigating the effects of the venom.

It is essential to note that snake antivenom is specific to certain snake species or families. Different venomous snakes have distinct venoms with unique compositions, so antivenom effectiveness is limited to the species or group it was produced against. In regions with multiple venomous snake species, medical professionals must correctly identify the snake responsible for the bite to administer the appropriate antivenom.

List of Key Companies Operating in Snake Antivenom Market:

MicroPharm     (U.K.)

BTG     International Inc. (U.S.)

VINS Bioproducts     Limited (India)

Pfizer Inc.     (U.S.)

SEQIRUS (CSL     Limited) (Australia)

Inosan Biopharma     (Mexico)

South Africa     Vaccine Producers (South Africa)

Rare Disease     Therapeutics, Inc. (U.S.)

Incepta Vaccine     Ltd. (Bangladesh)

Bioclon     Institute (Mexico)

Snakebites are the most neglected health problem in tropical and subtropical regions. According to the World Health Organization (WHO), globally, an estimated 2.7 million cases of snake envenoming are reported each year. An estimated 81,000 to 138,000 deaths occur each year due to venomous bites. Geographically, there is a vast disparity in distribution of these encounters.

What is the goal of the report?

The market     report presents the estimated size of the Snake Antivenom     Market at the end of the forecast period. The report also examines     historical and current market sizes.

During the     forecast period, the report analyzes the growth rate, market size, and     market valuation.

The report     presents current trends in the industry and the future potential of the     North America, Asia Pacific, Europe, Latin America, and the Middle East     and Africa markets.

The report offers     a comprehensive view of the market based on geographic scope, market     segmentation, and key player financial performance.

Furthermore, a detailed study of the competitive landscape of the Global Snake Antivenom Market has been given, presenting insights into the company profiles, financial status, recent developments, mergers and acquisitions, and the SWOT analysis. This research report will give a clear idea to readers about the overall Global Snake Antivenom Market scenario to further decide on this market project.

  Related Reports:

LASIK Eye Surgery Market

[sandipadole1]

Antivenoms Market 2018 Industry Price Trend, Size Estimation, Industry Outlook, Business Growth, Report Latest Research, Business Analysis and Forecast 2023 Analysis Research | 360 Market Updates

Antivenoms Market (2018 – 2023) report provides the newest industry data and industry future trends, allowing you to identify the products and end users driving Revenue growth and profitability. The Antivenoms market report lists the leading competitors and provides the insights strategic industry Analysis of the key factors influencing the market.

“Antivenoms Market report is anticipated to register a CAGR of 4.4% over a five years forecast period (2018 – 2023).”

Get a Sample PDF of Report @ https://www.360marketupdates.com/enquiry/request-sample/12883601

List of Major Key players operating in the Global Antivenoms Market are –

PFIZER INC

BIOCLON INSTITUTE

CSL LIMITED

BTG PLC

MERCK AND CO.

SIGMA ALDRICH

MICROPHARM

BOEHRINGER-INGELHEIM

The global antivenoms market has been estimated to reach USD 152.31 million in 2017.The market is expected to register a CAGR of 4.4% during the forecast period 2018 to 2023. North America is dominating the market due to increasing antivenom products and research & development for effective antivenom products in that region. Increasing Awareness on Antivenoms Available Snake bite is a neglected public health issue in many tropical and subtropical countries. About 5 million snake bites occur each year, resulting in up to 2.5 million envenoming’s (poisoning from snake bites), at least 100 000 deaths and around three times as many amputations and other permanent disabilities. But due to the involvement of international health organizations for producing safe and effective antivenoms people are aware about such antivenoms drugs. Additionally, recent advancement in pharmaceuticals is also fuelling the global antivenom market. High Cost of Available Antivenoms Antivenom production is difficult and expensive. The cost of some antivenom has increased dramatically over the last two decades, making treatment unaffordable for most of the people who need it. Increasing prices have suppressed demand and the treatment has declined significantly, or disappeared entirely in some areas. Inappropriate procurement and medicine distribution strategies in few countries contribute to manufacturers ceasing the production of antivenom or increasing the prices of antivenom. The high cost of the drug, which is around USD 540 per four vial treatment is an example to say that the product never reached many people who cannot afford the treatment. Also, preparation of the correct immunogens (snake venoms), lack of regulatory capacity for the control of antivenoms in countries, and weak health systems and lack of data are acting restraints the Global Antivenom market. North America to Dominate the Market The Global Antivenom Market is segmented into by animals (snakes, scorpion, spiders and others), by type of antivenoms (polyvalent heterologous, monovalent heterologous, homologous and small molecule anti-toxins) and geography. . By geography it is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa and South America. North America contributes a major share in antivenom market due to the establishment of snake poison control centers, increase in antivenom products and rise in clinical trial conducting firms for antivenom products and established healthcare facilities in that region.

Share your query before purchasing this report @ https://www.360marketupdates.com/enquiry/pre-order-enquiry/12883601

Scope of the Report:

The report analyses Antivenoms market, which includes –

Analysis of the growth of Antivenoms market in global and regional level including Asia-Pacific, Americas, and EMEA.

The report provides Antivenoms market analysis for key countries including the US, Canada, Chile, China, India, Japan, the UK, Germany, France, and Italy.

The report offers country level Antivenoms market volume and value by end-user segment for the period 2012-2023.

Qualitative analysis of key market drivers and restraints, and analysis of their impacts on Antivenoms market are discussed.

The report provides competitive landscape at country level for the year 2018. It also covers key policies and initiatives, key deals, and key upcoming projects.

Highlighted points of Antivenoms Market Report:

Varying dynamics of the Antivenoms industry.

Prospective changes in sales volumes and worldwide share growth in upcoming years (2018-2023).

Antivenoms market report recognizes the key drivers of growth and challenges of the key industry players.

Competitors profiles along with product description, overview, and business data.

A complete analysis of market risks, opportunities, limitations, and growth of the market.

Market driving and restraining factors.

Delivers information on the historical and current market size and the future potential of the market.

Antivenoms market report provides a comprehensive analysis of the market with respect to market dynamics, competitive analysis, and upcoming trends of the market.

Purchase this report (Price 4250 USD for a single-user license) @ https://www.360marketupdates.com/purchase/12883601

Reasons to Purchase Antivenoms Market Report:

The report analyses how stringent emission control norms will drive the global Antivenoms market.

Analyzing various perspectives of the market with the help of Porter’s five forces analysis.

Study on the product type that is expected to dominate the market.

Study on the regions that are expected to witness the fastest growth during the forecast period.

Identify the latest developments, market shares and strategies employed by the major Antivenoms market players.

3 months’ analyst support along with the Market Estimate sheet (in excel).

In this study, the years considered to estimate the market size of Antivenoms:

History Year: 2013-2017 Base Year: 2017 Estimated Year: 2018 Forecast Year 2018 to 2023

Look into Table of Content of Antivenoms Market Report @ https://www.360marketupdates.com/TOC/12883601#TOC

Contact Info: -

360 Market Updates

Mr. Ajay More

USA: +1 424 253 0807

UK: +44 203 239 8187

sales@360marketupdates.com

[market-research-blog-land]

Anti-Venom Market 2019 by Demand, Applications,Regional Analysis & Key Players – Medtoxin Venom Laboratories, Alomone Labs, Sigma Aldrich, Wyeth Pharmaceuticals

Anti-Venom Market

Antivenom, also known as antivenin, venom antiserum and antivenom immunoglobulin, is a medication made from antibodies which is used to treat certain venomous bites and stings. They are recommended only if there is significant toxicity or a high risk of toxicity. The specific antivenom needed depends on the species involved. It is given by injection.

Get a Sample Report @ https://www.reportsweb.com/inquiry&RW00012326010/sample

The market research report on the Global Anti-Venom Market by Reports Web is a prominent part of the life sciences portfolio and offers insights into the leading trends in the market and potential drivers, including the growth of the Global Anti-Venom Market Industry. It provides a comprehensive study comprising of a top-to-bottom research on the Anti-Venom market dynamics, including growth drivers, market size, application, challenges and potential growth opportunities, with a key focus on not only the global market but also the regional market. 

Market Segment by Manufacturers, this report covers

Medtoxin Venom Laboratories, Institute of Immunology, Alomone Labs, Sigma Aldrich, Wyeth Pharmaceuticals, Protherics PLC, Bharat Serums and Vaccines, Butantan Institute, Haffkine Bio-Pharmaceutical Corporation, Micropaharm Limited.

Market Segment by Type, coversCytotoxic, Neurotoxic, Haemotoxic, Cardiotoxic, Myotoxic.

Market Segment by Applications, can be divided intoSnake, Spider, Scorpion.

Market Segment by Regions, regional analysis coversNorth America (United States, Canada and Mexico), Europe (Germany, France, UK, Russia and Italy), Asia-Pacific (China, Japan, Korea, India and Southeast Asia), South America (Brazil, Argentina, Colombia etc.), Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Get Discount for this report: https://www.reportsweb.com/inquiry&RW00012326010/discount

1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.5 Market by Application 1.6 Study Objectives 1.7 Years Considered

2 Global Growth Trends 2.1 Anti-Venom Market Size 2.2 Anti-Venom Growth Trends by Regions 2.3 Industry Trends

3 Market Share by Key Players 3.1 Anti-Venom Market Size by Manufacturers 3.2 Anti-Venom Key Players Head office and Area Served 3.3 Key Players Anti-Venom Product/Solution/Service 3.4 Date of Enter into Anti-Venom Market 3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product 4.1 Global Anti-Venom Sales by Product 4.2 Global Anti-Venom Revenue by Product 4.3 Anti-Venom Price by Product

5 Breakdown Data by End User 5.1 Overview 5.2 Global Anti-Venom Breakdown Data by End User

Buy This Report @ https://www.reportsweb.com/buy&RW00012326010/buy/3480

About ReportsWeb: ReportsWeb.com is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers. We provide best in class customer service and our customer support team is always available to help you on your research queries.

Contact Us: Call: +1-646-491-9876 Email: sales@reportsweb.com

from Blogger https://ift.tt/2udpxLP via IFTTT

[niteshagrawals-blog]

Anti-venom Market 2018-2023 Top Companies Revenue Shortage Forecast

Anti-venom is made up of hyperimmune globulins and various other proteins extracted from the serum of various animals. In the process animals have been immunized with the venom of a snake, and then proteins are extracted from it. Anti-venom is currently the cornerstone of therapy for the victims of venomous snake bites and has reduced the mortality of this condition. It can be species-specific, regional, or polyvalent. For instance, anti-venom directed against coral snake venom is regenerated by immunizing horses with venom from the eastern coral snake i.e. Micrurus fulvius. The use of anti-venom is associated with various adverse reactions and so is given to only those victims who develop local, systemic, or laboratory evidence of envenoming. The use of epinephrine, corticosteroids, and antihistamines is also recommended before anti-venom administration as it helps to reduce the occurrence and severity of acute or delayed hypersensitivity reactions which may occur in 20 to 90% of cases.

According to the World Health Organization (WHO), snake antivenom immunoglobulins is the only specific treatment for envenoming by snakebites. It is also estimated that nearly 4.5 to 5.4 million people are bitten by snakes in a year, and around 1.8 to 2.7 million out of them develop clinical illness after a snakebite.

It is noted that the increasing cases of snake bites and increasing government funding for R&D are the key factors driving the anti-venom market. Various other factors such as the increasing patient pool, unmet medical needs, increasing awareness about antivenoms, enhancing regulatory framework, and increasing government assistance are continuously contributing to the growth of the global anti-venom market. Despite these drivers, there are some setbacks associated with the global anti-venom market. The high cost of available anti-venom, strict FDA regulations, difficult preparation of anti-venoms, and poor healthcare system in low- and middle-income countries may hinder the growth of the market to a considerable extent. It is estimated that the Anti-Venom market is expected to grow at a CAGR 6.5% during the forecast period of 2017–2023.

Get Exclusive Sample Copy @ https://www.marketresearchfuture.com/sample_request/5859

Market Segmentation of Anti-venom Market:

The global anti-venom market is segmented by type, type of species, mode of action, product type, and end-user. On the basis of type, the global anti-venom market is classified as polyvalent heterologous antivenom, monovalent heterologous antivenom, homologous antivenom, and small molecule anti-toxins. On the basis of type of species, the global anti-venom market is classified as snakes, scorpions, spiders, and others. The snake segment is further classified as common cobra, common krait, Russell viper, and others. On the basis of mode of action, the global anti-venom market is classified as cytotoxic, neurotoxic, haemotoxic, cardiotoxic, myotoxic, and others. On the basis of product type, the global anti-venom market is classified as snake anti-venom, scorpion anti-venom, spider anti-venom, and others. On the basis of end-user, the global anti-venom market is segmented into hospitals, clinics, ambulatory surgical centers, and others.

Avail Premium Discount @ https://www.marketresearchfuture.com/check-discount/5859

Top Players in Anti-venom Market:

Allison Medical, Inc., Artsana S.p.a., B. Braun Melsungen AG, Becton, Dickinson and Company, Boston Scientific Corporation, Hamilton Company, Hill-Rom, Hu-Friedy Mfg. Co., LLC, Johnson & Johnson Services, Inc, Medline Industries, Inc., Medtronic plc, Novo Nordisk A/s, Owen Mumford, Ltd., Roboz Surgical Instrument, Smiths Medical, Stryker Corporation, Terumo Corporation, Thermo Fisher Scientific, UltiMed, Inc., Ypsomed Holding AG, and others.

Intended Audience

Pharmaceutical Companies

Research and Development (R&D) Companies

Diagnostic Laboratories

Government Research Institutes

Academic Institutes and Universities

Regional Analysis of Anti-venom Market:

The Americas dominates the anti-venom market owing to the increasing cases of snake bites, and scorpion bites and high healthcare expenditure.

Europe holds the second position in the anti-venom market. The financial support by the government towards research and development and improvement in reimbursement scenario are expected to drive the European anti-venom market. According to the data suggested by Eurostat, it is observed that among the EU Member States, the highest value of healthcare expenditure was recorded in Germany in 2014 i.e. EUR 321 billion which is further followed by France with EUR 237 billion and United Kingdom with EUR 223 billion. In 2016, the R&D expenditure in the pharmaceutical industry was EUR 35000 million, suggested by the European Federation of Pharmaceutical Industries and Association.

Asia Pacific is the fastest growing anti-venom market owing to a huge patient pool and increasing advancements in pharmaceuticals. According to the Indian Brand Equity Foundation (IBEF), in 2016 the generics market of India stood at USD 26.1 billion. As per the statistics suggested by the World Health Organization (WHO), it has been estimated that around 2.8 million people are bitten by snakes, and nearly 46 900 people die from snakebite every year.

The Middle East and Africa holds the lowest share of the global market due to slow development, lack of technical knowledge, and poor medical facilities.

Major Table of Content for Anti-venom Market:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

4.5 Macroeconomic Indicators

TOC Continued….!

Do You Have Specific Requirement? Ask to Our Experts @ https://www.marketresearchfuture.com/enquiry/5859

About US: Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. Contact Us: Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune - 411028 Maharashtra, India Phone: +1 646 845 9312 Email: sales@marketresearchfuture.com

[medicaldevicetech]

Anti-Venom Market 2020- Report, Global Trends and Research By Top Companies

Anti-Venom Market Driven by Enhancing Regulatory Framework

The recent report by Market Research Future (MRFR) predicts the global anti-venom market value will be expanding with a healthy CAGR of 6.5% over the forecast period (2017–2023).

Biotechnology, as well as the healthcare industry, is noting a considerable demand from developing nations globally. The prominent reason behind the strong growth of the anti-venom market is the growing demand for anti-venom treatment, as it is the only authorized treatment for snake bite, without any alternative treatment available. Moreover, violation of forest lands for housing and agricultural needs has gotten humans close to poisonous animals and insects, thereby increasing the prevalence of venomous bites. In addition, the prevalence of snake bites, scorpion bites, as well as other animal or insect bites like fish stings is an additional factor playing a major role in the anti-venom market growth.

Various research and development (R&D) activities taking place continuously that provide advanced drugs and standard treatment for poisonous insect bite further uplifts the market position of anti-venom. Growing demand for anti-venoms in the emerging countries is encouraging the prominent players to penetrate these markets, such as in India and Africa in order to offer anti-venom products at a cost-effective price. This is yet another driver responsible for the growth of the global anti-venoms market.

In contrast, the high cost of anti-venom due to the high production cost in a few regions could hamper the growth of the anti-venom market. However, the rapid development of the economic conditions around the world is creating massive opportunities for the expansion of the anti-venom market. The improving economy is increasing the individual per capita income, which will increase the spending capacity on health care. The contribution of the developing countries of Asia Pacific as well as the Middle East coupled with the growing population and increasing capita income will foster the growth of the market.

Segmentation

The global anti-venom market is segmented on the basis of type, type of species, mode of action, product type, and end user.

The global anti-venom market, by type, is categorized into polyvalent heterologous antivenom, monovalent heterologous antivenom, homologous antivenom, and small molecule anti-toxins.

By species type, the global anti-venom market is segmented into snakes, scorpions, spiders, and others. The snake segment is further classified as a common cobra, common krait, Russell Viper, and others.

Based on the mode of action, the global anti-venom market is divided into cytotoxic, neurotoxic, haemotoxic, cardiotoxic, myotoxic, and others.

The product types in the global anti-venom market include snake anti-venom, scorpion anti-venom, spider anti-venom, and others.

End-user-wise, the global anti-venom market is segmented into hospitals, clinics, ambulatory surgical centers, and others.

Regional Analysis

The regions among which the global anti-venom market is segmented into are Asia Pacific, Europe, Americas, and the Middle East and Africa.

At a global level, the Americas will be leading the anti-venom market in the coming years on account of the increasing cases of snake bites, as well as scorpion bites coupled with the high healthcare expenditure.

Europe will be securing the second position in the global anti-venom market, due to the strong financial support by the government for research and development along with the improvement in reimbursement scenario, driving the Europe anti-venom market. As per the data furnished by Eurostat, it is noted that among all the EU Member States, the highest value of healthcare expenditure has been recorded in Germany in the year 2014, which was around EUR 321 billion, followed by France at the value of EUR 237 billion and United Kingdom valued at EUR 223 billion. In the year 2016, the R&D expenditure for the pharmaceutical industry was at the value of EUR 35000 million, stated by the European Federation of Pharmaceutical Industries and Association.

Furthermore, Asia Pacific is touted to be the fastest growing anti-venom market, resulting from the massive patient pool coupled with the increasing advancements in pharmaceuticals. As per the Indian Brand Equity Foundation (IBEF), the generics market in the country was around USD 26.1 billion in the year 2016. Moreover, according to the statistics by the World Health Organization (WHO), around 2.8 million people are bitten by snakes, and close to 46 900 people succumb to snakebites every year.

Lastly, the market in the Middle East and Africa account for the lowest share of the global market owing to the restricted economic development, lack of technical knowhow, and poor medical facilities.

Competitive Landscape

Thermo Fisher Scientific, Ypsomed Holding AG, Artsana S.p.a., B. Braun Melsungen AG, Becton, Dickinson and Company, Allison Medical, Inc., cHill-Rom, Hu-Friedy Mfg. Co., LLC, Johnson & Johnson Services, Inc, Medline Industries, Inc., Medtronic plc, Allison Medical, Inc., Owen Mumford, Ltd., Roboz Surgical Instrument, Smiths Medical, Stryker Corporation, Terumo Corporation, Novo Nordisk A/s, UltiMed, Inc., Boston Scientific Corporation, are some of the leading companies in the global anti-venom market.

Industry Update

February 2019 – Kenya’s Ministry of Health is set to produce anti-snake venom for ensuring a sustainable supply, in addition to developing few policies, guidelines as well as processes for identifying cheaper high-quality brands for licensing. The products will be procured and distributed to public health facilities by the country’s medical supplies authority.

Read More @https://www.marketresearchfuture.com/reports/anti-venom-market-5859

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact: Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune – 411028 Maharashtra, India +1 646 845 9312 Email: sales@marketresearchfuture.com

NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

[bunnyroy]

Global Antivenom Market 2018 Industry, Analysis, Research, Share, Growth, Sales, Trends, Supply, Forecast To 2022

Global Antivenom Market 2018 Industry, Analysis, Research, Share, Growth, Sales, Trends, Supply, Forecast To 2022

MarketResearchNest.com adds “Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Antivenom Market 2017 Forecast to 2022” new report to its research database. The records spread across 118 with more than one tables and figures in it.   Antivenom, also known as antivenin, venom antiserum and antivenom immunoglobulin, is a medication made from antibodies which is…

[saojip13]

Antivenom market is poised to grow around 6.0% CAGR by 2025

Global Antivenom Market: By Antivenom Type (Monovalent, Bivalent, Trivalent, Tetravalent, and Polyvalent), By Reptile Type (Snakes, Scorpions, Spiders, and Others), By Immunoglobulin Type (Homologous and Heterologous), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others), and Geography (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa) - Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2014-2018 and Forecast 2019-2025

Global Antivenom Market Report Description:

Global antivenom market report gives comprehensive outlook on antivenom products across the globe with special emphasis on key regions such as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa (MEA). The report on antivenom market gives historical, current, and future market sizes (US$ Mn) on the basis of antivenom type, reptile type, immunoglobulin type, distribution channel, and geographic regions. This report studies antivenom market dynamics elaborately to identify the current market trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, antivenom market report includes the competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, antivenom market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs. Key stakeholders of the antivenom market report include raw material suppliers, manufacturers, marketers, hospitals, physician offices, policy makers, and healthcare service providers who are engaged in usage and advocacy of antivenom products.

Get Access to Report Sample: https://www.alexareports.com/report-sample/170550

Key players profiles in the global antivenom market include:

Vins Bioproducts Limited (India)

Bharat Serum and Vaccines Limited (India)

CSL Limited (Victoria)

Rare Disease Therapeutics, Inc. (U.S.)

F. Hoffmann-La Roche AG (Switzerland)

Instituto Bioclon, S.A. de C.V.(Mexico)

Incepta Vaccine Ltd. (Bangladesh)

BTG Plc (UK)

Merck & Co., Inc. (U.S)

Pfizer Inc. (U.S.)

Key Features of the Report:

The report provides granular level information about the market size, regional market share, historic market (2014-2018) and forecast (2019-2025)

The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies

The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market

The report tracks recent innovations, key developments and startup’s details that are actively working in the market

The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario

The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Look insights of Antivenom Market Research Report, Click the Link Here: https://www.alexareports.com/send-an-enquiry/170550

Detailed Segmentation

By Antivenom Type

o Monovalent

o Bivalent

o Trivalent

o Tetravalent

o Polyvalent

By Reptile Type

o Snakes

o Scorpions

o Spiders

o Others

By Immunoglobulin Type

o Homologous

o Heterologous

By Distribution Channel

o Hospital Pharmacies

o Retail Pharmacies

o Others

About Us:

Alexa Reports is a globally celebrated premium market research service provider, with a strong legacy of empowering business with years of experience. We help our clients by implementing decision support system through progressive statistical surveying, in-depth market analysis, and reliable forecast data. Alexa Reports is a globally celebrated premium market research service provider, with a strong legacy of empowering business with years of experience. We help our clients by implementing decision support system through progressive statistical surveying, in-depth market analysis, and reliable forecast data.

Contact Us:

Alexa Reports

Ph no: +1-408-844-4624 / +91- 7030626939

Email: sales@alexareports.com

Site: https://www.alexareports.com